+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Therapeutic Respiratory Devices Market - Global Forecast to 2030- Product Image
Therapeutic Respiratory Devices Market - Global Forecast to 2030- Product Image
Sale

Therapeutic Respiratory Devices Market - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5613205
UP TO OFF until Jan 01st 2026
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Therapeutic Respiratory Devices Market grew from USD 21.30 billion in 2024 to USD 24.68 billion in 2025. It is expected to continue growing at a CAGR of 15.75%, reaching USD 51.25 billion by 2030.

The therapeutic respiratory devices landscape is undergoing a pivotal evolution driven by accelerating global incidence of respiratory disorders, heightened patient expectations, and relentless innovation. Advancements in inhaler technologies, nebulization platforms, and oxygen therapy equipment are converging with digital health solutions to create integrated treatment ecosystems that improve adherence and clinical outcomes. Moreover, demographic shifts-including an aging population and increasing urban air pollution-are expanding the addressable patient base for asthma, chronic obstructive pulmonary disease, cystic fibrosis, pulmonary hypertension and sleep apnea therapies. Simultaneously, health systems are seeking cost-effective, patient-centric interventions that can be delivered across home care settings, hospitals, and specialty clinics without compromising safety or efficacy. As telemedicine and remote monitoring become entrenched in care pathways, demand for devices with smart connectivity and adjustable settings continues to rise. This introduction outlines the key drivers reshaping market dynamics, highlights emerging technology intersections, and sets the stage for an in-depth exploration of transformative shifts, regulatory impacts, segmentation insights, regional trends, competitive strategies, and actionable recommendations for stakeholders poised to lead in the next phase of respiratory care innovation.

Transformative Shifts in the Landscape

Healthcare providers, payers, and device manufacturers are confronting a series of transformative shifts that are redefining standards of care for respiratory patients. Firstly, the integration of sensor-enabled inhalers and nebulizers with mobile applications is enabling real-time adherence monitoring, personalized dosing reminders, and remote clinician oversight. Secondly, portable and wearable technologies are transcending traditional boundaries, empowering patients to self-manage conditions outside clinical settings while feeding critical data into chronic disease management programs. Thirdly, regulatory bodies are adopting expedited review pathways and harmonizing global standards to accelerate the approval of novel drug-device combinations and digital therapeutics. In parallel, sustainability considerations are prompting the development of reusable and recyclable device components, reducing both long-term costs and environmental impact. Additionally, the convergence of advanced materials science and microfluidics is yielding next-generation inhalation platforms capable of targeted deep-lung delivery and precise aerosolization profiles. Altogether, these advancements are not only elevating patient engagement and outcomes but also compelling manufacturers to reimagine product roadmaps, forge strategic alliances with technology firms, and secure new revenue streams in a highly competitive environment.

Cumulative Impact of United States Tariffs 2025

The implementation of the United States tariff schedule for 2025 has introduced a cumulative cost burden across the therapeutic respiratory devices value chain. Higher duties on imported inhaler canisters, nebulizer assemblies, and oxygen concentrator components have compelled manufacturers to reevaluate sourcing strategies and reprice their product portfolios. Supply chain stakeholders are increasingly transitioning critical production to North American facilities or entering into toll-manufacturing partnerships with domestic contract manufacturers to mitigate tariff exposure. This shift, however, carries capital investment implications and may result in temporary capacity constraints. Concurrently, device providers are renegotiating supplier contracts to lock in forward pricing and exploring tariff-engineering solutions, such as material substitutes and modular design reconfigurations, to minimize duties. On a macro level, heightened trade tensions and regional protectionism have amplified emphasis on nearshoring and regional free-trade agreements, catalyzing new cross-border alliances. As a result, the interplay between regulatory compliance, cost containment and supply resilience is dictating a more agile, locally anchored approach to manufacturing and distribution within the U.S. market.

Key Segmentation Insights Driving Market Dynamics

The market exhibits pronounced heterogeneity when dissected by product type, technology, end user, disease indication, distribution channel, and optional features. Inhalers, nebulizers, and oxygen therapy devices represent the primary product categories, with inhalers further differentiated into dry powder, metered-dose, and soft mist variants. Within these, multi-dose and single-dose dry powder inhalers are distinguished by blister-based or capsule-based delivery, while metered-dose inhalers leverage pressurized canister systems. Nebulizer platforms span jet, mesh, and ultrasonic modalities, with disposable and reusable jet nebulizers co-existing alongside active and passive mesh designs. Oxygen therapy solutions encompass liquid oxygen devices, concentrators, and cylinders. Compact, high-performance, and portable device architectures define the technology segmentation, the latter featuring handheld and wearable form factors optimized for mobility and discreet use. End users range from home care settings to hospitals-academic, private, and public-and specialty clinics, each demanding tailored service agreements and support infrastructure. Disease indications include asthma, COPD subtypes chronic bronchitis and emphysema, cystic fibrosis, pulmonary hypertension, and sleep apnea, which subdivides into central, complex, and obstructive variants. Distribution channels extend through hospital pharmacies, online pharmacies via direct-to-consumer or e-commerce platforms, and traditional retail pharmacies. Finally, optional features such as adjustable settings, noise reduction, and smart connectivity-with app integration for health monitoring or usage tracking and Bluetooth enablement-are becoming core differentiators, providing actionable patient data and reinforcing brand loyalty.

Key Regional Insights Shaping Global Opportunities

Geographic dynamics are pivotal in shaping market opportunities and strategic investments. In the Americas, robust reimbursement frameworks, high per capita healthcare spending, and mature home care infrastructures fuel strong demand for connected, user-friendly respiratory devices. Meanwhile, in Europe, Middle East & Africa, regulatory harmonization under the European Medical Device Regulation, growing public-private partnerships, and upscale adoption of e-health solutions are driving device modernization and cross-border procurement. In the Asia-Pacific region, rising incidence of pollution-related respiratory diseases, expanding middle-income populations, and government-led healthcare expansions in China and India are unlocking high-growth corridors for both entry-level and advanced therapeutic platforms. Furthermore, localized manufacturing incentives and strategic alliances with multinational corporations are enhancing supply chain resilience and optimizing market access. Across all regions, cost containment and value-based healthcare models are intensifying the need for devices that demonstrate clinical efficacy, operational efficiency, and integrated data-driven patient management.

Key Companies Insights Spotlighting Competitive Landscape

The competitive landscape is characterized by a blend of established conglomerates and specialized innovators driving rapid technological progression and market consolidation. Becton, Dickinson and Company continues to expand its inhaler portfolio through R&D investments and strategic acquisitions, while BMC Medical Co., Ltd. emphasizes cost-effective oxygen concentrator solutions tailored for emerging markets. CAIRE Inc. leverages modular manufacturing to scale liquid oxygen devices globally, and Chart Industries, Inc. integrates cryogenic expertise to enhance oxygen cylinder storage and transport. Compumedics Limited has carved a niche in sleep apnea diagnostics, complementing its CPAP device offerings. Drägerwerk AG & Co. KGaA and Fisher & Paykel Healthcare Limited secure leadership in ventilator and humidifier technologies, respectively. GE Healthcare and Siemens Healthineers AG capitalize on their imaging and diagnostic platforms to integrate comprehensive respiratory care modules. Invacare Corporation and Vyaire Medical, Inc. focus on home care solutions, whereas Koninklijke Philips N.V. advances cloud-enabled therapy management. Medtronic PLC and Nihon Kohden Corporation prioritize innovation in monitoring and telehealth interoperability, and Teleflex Incorporated explores novel drug-delivery mechanisms. Each organization competes on the axes of product breadth, digital integration, after-sales support, and global distribution networks.

Actionable Recommendations for Industry Leaders

Industry leaders must adopt a multifaceted strategy to capitalize on evolving market trends and mitigate emerging risks. First, prioritizing investment in advanced R&D initiatives-particularly in microfluidic aerosol generation and next-generation wearable inhalation platforms-will secure product differentiation and support patent portfolios. Second, establishing regional centers of excellence in North America, Europe, and Asia-Pacific can enhance supply chain resilience, reduce tariff implications, and accelerate regulatory approvals through local market expertise. Third, forging strategic alliances with digital health startups and cloud service providers will enable the seamless integration of smart connectivity, usage tracking, and predictive analytics into device ecosystems. Fourth, diversifying distribution channels by deepening partnerships with online pharmacies, e-commerce platforms, and telehealth networks will broaden reach and improve patient access. Fifth, embedding sustainability principles-such as recyclable components, energy-efficient compressors, and circular supply chains-will not only meet environmental goals but also appeal to socially conscious stakeholders. Sixth, designing modular service-and-maintenance contracts that leverage remote diagnostics and preventative care can reduce downtime and improve customer retention. Finally, aligning clinical validation studies with payers’ value-based procurement frameworks will demonstrate cost-effectiveness and facilitate favorable reimbursement terms, ensuring long-term revenue stability.

Conclusion

As the therapeutic respiratory devices market continues its rapid trajectory, stakeholders must remain agile, data-driven, and patient-focused. Embracing digital transformation across product development, manufacturing, and post-sales support will be critical to capturing market share. Strategic localization and tariff mitigation measures will safeguard supply chain continuity, while robust collaboration with regulatory authorities will expedite time to market. By integrating sustainable design principles and outcome-based service models, companies can fulfill both environmental and economic imperatives. Ultimately, sustained success will hinge on leveraging cross-disciplinary expertise-combining clinical insights, engineering innovation, and digital ecosystems-to deliver therapies that enhance patient quality of life and optimize healthcare resource utilization.

Market Segmentation & Coverage

This research report categorizes the Therapeutic Respiratory Devices Market to forecast the revenues and analyze trends in each of the following sub-segmentations:

  • Inhalers
    • Dry Powder Inhalers
      • Multi-Dose
      • Single Dose
        • Blister-Based
        • Capsule-Based
    • Metered-Dose Inhalers
      • Pressurized Metered-Dose Inhalers
    • Soft Mist Inhalers
  • Nebulizers
    • Jet Nebulizers
      • Disposable Jet Nebulizers
      • Reusable Jet Nebulizers
    • Mesh Nebulizers
      • Active Mesh Nebulizers
      • Passive Mesh Nebulizers
    • Ultrasonic Nebulizers
  • Oxygen Therapy Devices
    • Liquid Oxygen Devices
    • Oxygen Concentrators
    • Oxygen Cylinders
  • Compact Devices
  • High-Performance Devices
  • Portable Devices
    • Handheld Devices
    • Wearable Devices
  • Home Care Settings
  • Hospitals
    • Academic Hospitals
    • Private Hospitals
    • Public Hospitals
  • Specialty Clinics
  • Asthma
    • Mild Asthma
    • Moderate Asthma
    • Severe Asthma
  • Chronic Obstructive Pulmonary Disease
    • Chronic Bronchitis
    • Emphysema
  • Cystic Fibrosis
  • Pulmonary Hypertension
  • Sleep Apnea
    • Central Sleep Apnea
    • Complex Sleep Apnea
    • Obstructive Sleep Apnea
  • Hospital Pharmacies
  • Online Pharmacies
    • Direct-To-Consumer Channels
    • E-Commerce Platforms
  • Retail Pharmacies
  • Adjustable Settings
  • Noise Reduction Technology
  • Smart Connectivity
    • App Integration
      • Health Monitoring App
      • Usage Tracking App
    • Bluetooth Enabled

This research report categorizes the Therapeutic Respiratory Devices Market to forecast the revenues and analyze trends in each of the following sub-regions:

  • Americas
    • Argentina
    • Brazil
    • Canada
    • Mexico
    • United States
      • California
      • Florida
      • Illinois
      • New York
      • Ohio
      • Pennsylvania
      • Texas
  • Asia-Pacific
    • Australia
    • China
    • India
    • Indonesia
    • Japan
    • Malaysia
    • Philippines
    • Singapore
    • South Korea
    • Taiwan
    • Thailand
    • Vietnam
  • Europe, Middle East & Africa
    • Denmark
    • Egypt
    • Finland
    • France
    • Germany
    • Israel
    • Italy
    • Netherlands
    • Nigeria
    • Norway
    • Poland
    • Qatar
    • Russia
    • Saudi Arabia
    • South Africa
    • Spain
    • Sweden
    • Switzerland
    • Turkey
    • United Arab Emirates
    • United Kingdom

This research report categorizes the Therapeutic Respiratory Devices Market to delves into recent significant developments and analyze trends in each of the following companies:

  • Becton, Dickinson and Company
  • BMC Medical Co., Ltd.
  • CAIRE Inc.
  • Chart Industries, Inc.
  • Compumedics Limited
  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Nihon Kohden Corporation
  • Siemens Healthineers AG
  • Teleflex Incorporated
  • Vyaire Medical, Inc.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Therapeutic Respiratory Devices Market, by Product Type
8.1. Introduction
8.2. Inhalers
8.2.1. Dry Powder Inhalers
8.2.1.1. Multi-Dose
8.2.1.2. Single Dose
8.2.1.2.1. Blister-Based
8.2.1.2.2. Capsule-Based
8.2.2. Metered-Dose Inhalers
8.2.2.1. Pressurized Metered-Dose Inhalers
8.2.3. Soft Mist Inhalers
8.3. Nebulizers
8.3.1. Jet Nebulizers
8.3.1.1. Disposable Jet Nebulizers
8.3.1.2. Reusable Jet Nebulizers
8.3.2. Mesh Nebulizers
8.3.2.1. Active Mesh Nebulizers
8.3.2.2. Passive Mesh Nebulizers
8.3.3. Ultrasonic Nebulizers
8.4. Oxygen Therapy Devices
8.4.1. Liquid Oxygen Devices
8.4.2. Oxygen Concentrators
8.4.3. Oxygen Cylinders
9. Therapeutic Respiratory Devices Market, by Technology
9.1. Introduction
9.2. Compact Devices
9.3. High-Performance Devices
9.4. Portable Devices
9.4.1. Handheld Devices
9.4.2. Wearable Devices
10. Therapeutic Respiratory Devices Market, by End User
10.1. Introduction
10.2. Home Care Settings
10.3. Hospitals
10.3.1. Academic Hospitals
10.3.2. Private Hospitals
10.3.3. Public Hospitals
10.4. Specialty Clinics
11. Therapeutic Respiratory Devices Market, by Disease Indication
11.1. Introduction
11.2. Asthma
11.2.1. Mild Asthma
11.2.2. Moderate Asthma
11.2.3. Severe Asthma
11.3. Chronic Obstructive Pulmonary Disease
11.3.1. Chronic Bronchitis
11.3.2. Emphysema
11.4. Cystic Fibrosis
11.5. Pulmonary Hypertension
11.6. Sleep Apnea
11.6.1. Central Sleep Apnea
11.6.2. Complex Sleep Apnea
11.6.3. Obstructive Sleep Apnea
12. Therapeutic Respiratory Devices Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.3.1. Direct-To-Consumer Channels
12.3.2. E-Commerce Platforms
12.4. Retail Pharmacies
13. Therapeutic Respiratory Devices Market, by Optional Features
13.1. Introduction
13.2. Adjustable Settings
13.3. Noise Reduction Technology
13.4. Smart Connectivity
13.4.1. App Integration
13.4.1.1. Health Monitoring App
13.4.1.2. Usage Tracking App
13.4.2. Bluetooth Enabled
14. Americas Therapeutic Respiratory Devices Market
14.1. Introduction
14.2. Argentina
14.3. Brazil
14.4. Canada
14.5. Mexico
14.6. United States
15. Asia-Pacific Therapeutic Respiratory Devices Market
15.1. Introduction
15.2. Australia
15.3. China
15.4. India
15.5. Indonesia
15.6. Japan
15.7. Malaysia
15.8. Philippines
15.9. Singapore
15.10. South Korea
15.11. Taiwan
15.12. Thailand
15.13. Vietnam
16. Europe, Middle East & Africa Therapeutic Respiratory Devices Market
16.1. Introduction
16.2. Denmark
16.3. Egypt
16.4. Finland
16.5. France
16.6. Germany
16.7. Israel
16.8. Italy
16.9. Netherlands
16.10. Nigeria
16.11. Norway
16.12. Poland
16.13. Qatar
16.14. Russia
16.15. Saudi Arabia
16.16. South Africa
16.17. Spain
16.18. Sweden
16.19. Switzerland
16.20. Turkey
16.21. United Arab Emirates
16.22. United Kingdom
17. Competitive Landscape
17.1. Market Share Analysis, 2024
17.2. FPNV Positioning Matrix, 2024
17.3. Competitive Analysis
17.3.1. Becton, Dickinson and Company
17.3.2. BMC Medical Co., Ltd.
17.3.3. CAIRE Inc.
17.3.4. Chart Industries, Inc.
17.3.5. Compumedics Limited
17.3.6. Drägerwerk AG & Co. KGaA
17.3.7. Fisher & Paykel Healthcare Limited
17.3.8. GE Healthcare
17.3.9. Invacare Corporation
17.3.10. Koninklijke Philips N.V.
17.3.11. Medtronic PLC
17.3.12. Nihon Kohden Corporation
17.3.13. Siemens Healthineers AG
17.3.14. Teleflex Incorporated
17.3.15. Vyaire Medical, Inc.
18. ResearchAI
19. ResearchStatistics
20. ResearchContacts
21. ResearchArticles
22. Appendix
List of Figures
FIGURE 1. THERAPEUTIC RESPIRATORY DEVICES MARKET MULTI-CURRENCY
FIGURE 2. THERAPEUTIC RESPIRATORY DEVICES MARKET MULTI-LANGUAGE
FIGURE 3. THERAPEUTIC RESPIRATORY DEVICES MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 10. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2030 (%)
FIGURE 14. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2024 VS 2030 (%)
FIGURE 18. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 22. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 26. EUROPE, MIDDLE EAST & AFRICA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 27. THERAPEUTIC RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 28. THERAPEUTIC RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. THERAPEUTIC RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MULTI-DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY BLISTER-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CAPSULE-BASED, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRESSURIZED METERED-DOSE INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SOFT MIST INHALERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISPOSABLE JET NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY REUSABLE JET NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ACTIVE MESH NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PASSIVE MESH NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY LIQUID OXYGEN DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CYLINDERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COMPACT DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HIGH-PERFORMANCE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HANDHELD DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY WEARABLE DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 45. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 46. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ACADEMIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 47. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRIVATE HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 48. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PUBLIC HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 49. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 50. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 51. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 52. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 53. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MILD ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 54. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MODERATE ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 55. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SEVERE ASTHMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 56. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 57. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 58. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC BRONCHITIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 59. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY EMPHYSEMA, BY REGION, 2018-2030 (USD MILLION)
TABLE 60. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 61. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CYSTIC FIBROSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 62. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PULMONARY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 63. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 64. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CENTRAL SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 65. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COMPLEX SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 66. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OBSTRUCTIVE SLEEP APNEA, BY REGION, 2018-2030 (USD MILLION)
TABLE 67. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 68. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 69. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 70. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 71. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DIRECT-TO-CONSUMER CHANNELS, BY REGION, 2018-2030 (USD MILLION)
TABLE 72. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 73. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 74. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 75. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 76. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ADJUSTABLE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 77. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NOISE REDUCTION TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 78. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, BY REGION, 2018-2030 (USD MILLION)
TABLE 79. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, BY REGION, 2018-2030 (USD MILLION)
TABLE 80. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HEALTH MONITORING APP, BY REGION, 2018-2030 (USD MILLION)
TABLE 81. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY USAGE TRACKING APP, BY REGION, 2018-2030 (USD MILLION)
TABLE 82. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 83. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY BLUETOOTH ENABLED, BY REGION, 2018-2030 (USD MILLION)
TABLE 84. GLOBAL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 85. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 86. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 87. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 88. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 89. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 90. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 91. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 92. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 93. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 94. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 96. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 98. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 99. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 100. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 101. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 102. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 103. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 104. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 105. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 106. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 107. AMERICAS THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 108. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 109. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 110. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 111. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 112. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 113. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 114. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 115. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 116. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 117. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 118. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 119. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 120. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 121. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 122. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 123. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 124. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 125. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 126. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 127. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 128. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 129. ARGENTINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 130. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 131. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 132. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 133. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 134. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 135. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 136. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 137. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 138. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 139. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 141. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 143. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 144. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 145. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 146. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 147. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 148. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 149. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 150. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 151. BRAZIL THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 152. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 153. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 154. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 155. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 156. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 157. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 158. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 159. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 160. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 161. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 162. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 163. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 164. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 165. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 166. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 167. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 168. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 169. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 171. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 172. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 173. CANADA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 174. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 175. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 176. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 177. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 178. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 179. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 180. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 181. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 182. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 183. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 184. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 185. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 186. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 187. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 188. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 189. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 190. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 191. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 192. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 193. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 194. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 195. MEXICO THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 196. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 197. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 198. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 199. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 200. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 201. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 202. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 203. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 204. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 205. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 206. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 207. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 208. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 209. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 210. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 211. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 212. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 213. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 214. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 215. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 216. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 217. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 218. UNITED STATES THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 219. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 220. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 221. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 222. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 223. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 224. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 225. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 226. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 227. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 228. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 229. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 230. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 231. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 232. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 233. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 234. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 235. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 236. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 237. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 238. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 239. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 240. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 241. ASIA-PACIFIC THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 242. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 243. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 244. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 245. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 246. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 247. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 248. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 249. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 250. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 251. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 252. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 253. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 254. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 255. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 256. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 257. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 258. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 259. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 260. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 261. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 262. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 263. AUSTRALIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 264. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 265. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 266. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 267. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 268. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 269. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 270. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 271. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 272. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 273. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 274. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 275. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 276. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2030 (USD MILLION)
TABLE 277. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISEASE INDICATION, 2018-2030 (USD MILLION)
TABLE 278. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ASTHMA, 2018-2030 (USD MILLION)
TABLE 279. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2018-2030 (USD MILLION)
TABLE 280. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SLEEP APNEA, 2018-2030 (USD MILLION)
TABLE 281. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 282. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY ONLINE PHARMACIES, 2018-2030 (USD MILLION)
TABLE 283. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OPTIONAL FEATURES, 2018-2030 (USD MILLION)
TABLE 284. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SMART CONNECTIVITY, 2018-2030 (USD MILLION)
TABLE 285. CHINA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY APP INTEGRATION, 2018-2030 (USD MILLION)
TABLE 286. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
TABLE 287. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY INHALERS, 2018-2030 (USD MILLION)
TABLE 288. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY DRY POWDER INHALERS, 2018-2030 (USD MILLION)
TABLE 289. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY SINGLE DOSE, 2018-2030 (USD MILLION)
TABLE 290. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY METERED-DOSE INHALERS, 2018-2030 (USD MILLION)
TABLE 291. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 292. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 293. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZERS, 2018-2030 (USD MILLION)
TABLE 294. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN THERAPY DEVICES, 2018-2030 (USD MILLION)
TABLE 295. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 296. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE DEVICES, 2018-2030 (USD MILLION)
TABLE 297. INDIA THERAPEUTIC RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2030 (

Companies Mentioned

  • Becton, Dickinson and Company
  • BMC Medical Co., Ltd.
  • CAIRE Inc.
  • Chart Industries, Inc.
  • Compumedics Limited
  • Drägerwerk AG & Co. KGaA
  • Fisher & Paykel Healthcare Limited
  • GE Healthcare
  • Invacare Corporation
  • Koninklijke Philips N.V.
  • Medtronic PLC
  • Nihon Kohden Corporation
  • Siemens Healthineers AG
  • Teleflex Incorporated
  • Vyaire Medical, Inc.

Methodology

Loading
LOADING...

Related Topics

Related Reports

Therapeutic Respiratory Devices Market Size, Share & Trends Analysis Report By Product Type (Nebulizer, Humidifiers), By Technology (Electrostatic Filtration, HEPA Filter Technology), By Filter, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Therapeutic Respiratory Devices Market Size, Share & Trends Analysis Report By Product Type (Nebulizer, Humidifiers), By Technology (Electrostatic Filtration, HEPA Filter Technology), By Filter, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 144 Pages
  • Global
From
Therapeutic Respiratory Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Therapeutic Respiratory Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 100 Pages
  • Global
From
Therapeutic Respiratory Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F - Product Image

Therapeutic Respiratory Devices Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F

  • Report
  • 183 Pages
  • Global
From
Therapeutic Respiratory Devices - Global Strategic Business Report - Product Image

Therapeutic Respiratory Devices - Global Strategic Business Report

  • Report
  • 92 Pages
  • Global
From
Respiratory Devices and Equipment (Therapeutic) Market Report 2025 - Product Image

Respiratory Devices and Equipment (Therapeutic) Market Report 2025

  • Report
  • 175 Pages
  • Global
From

About the Therapeutic Respiratory Devices Market

The Therapeutic Respiratory Devices market is a subset of the larger Respiratory Devices market. It includes devices used to treat respiratory diseases, such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. These devices are used to deliver medication, humidify air, and provide oxygen therapy. They can also be used to monitor lung function and detect early signs of respiratory distress. Therapeutic Respiratory Devices are typically used in hospitals, clinics, and home settings. They are designed to improve patient comfort and quality of life, as well as reduce the risk of complications from respiratory diseases. Some companies in the Therapeutic Respiratory Devices market include Philips Respironics, ResMed, Fisher & Paykel Healthcare, and Vyaire Medical. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.